Omega Funds Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Omega Funds's estimated annual revenue is currently $7.5M per year.(i)
  • Omega Funds's estimated revenue per employee is $208,333

Employee Data

  • Omega Funds has 36 Employees.(i)
  • Omega Funds grew their employee count by 20% last year.

Omega Funds's People

NameTitleEmail/Phone
1
FounderReveal Email/Phone
2
VP, Data ScienceReveal Email/Phone
3
Executive PartnerReveal Email/Phone
4
Assistant ControllerReveal Email/Phone
5
Associate General CounselReveal Email/Phone
6
PartnerReveal Email/Phone
7
Investment AssociateReveal Email/Phone
8
Executive AssistantReveal Email/Phone
9
Investment AssociateReveal Email/Phone
10
Associate, ESG, Investor Relations & OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8988.2M305729%N/AN/A
Add Company

What Is Omega Funds?

Omega Funds is a leading international investment firm that creates and invests in life sciences companies that target the world’s most urgent medical needs. ? is the last letter of the Greek alphabet. Our investment process starts by focusing on the end goal – delivering impactful medicines to patients. We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas, including oncology, immunology, rare diseases, precision medicine and others. Early seed or late stage public financing. Large markets or rare diseases. Established targets or novel technologies. We are guided by our conviction in people, products and breakthrough ideas, not by conventional categories. Our investments span a variety of instruments from early venture rounds, to late-stage investing, direct secondary transactions, as well as company founding and creation. Omega Funds has raised more than $1 billion since its inception in 2004 and is headquartered in Boston, Massachusetts, USA.

keywords:N/A

N/A

Total Funding

36

Number of Employees

$7.5M

Revenue (est)

20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Omega Funds News

2022-04-13 - RA, Jeito and Omega back a small Swiss biotech to enter an I ...

We are a little over a year from the clinic with our primary project and we wanted to raise the funds to move that project to clinical proof of...

2022-03-22 - Ligand takes a crack at a SPAC to buoy spun-off antibody ...

Ligand announced the deal with APAC Thursday, which will fund the antibody ... CEO of VC firm Omega Funds, said in a February interview with Fierce Biotech.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6M360%N/A
#2
$5.9M36-8%N/A
#3
$6.7M36-23%$26M
#4
$3.7M36-5%N/A
#5
$10.2M366%N/A